The most comprehensively characterized transcription factor is nuclear factor-κB (NF-κB), which is regulated by BRD4 via binding to the acetylated lysine-310 residue of its RelA subunit in cancer cells (Huang et al., 2009). Here, NFKB1 is linked to cancer.